NCT07666854

Brief Summary

Pulmonary rehabilitation (PR) is a key non-pharmacological intervention for patients with chronic obstructive pulmonary disease (COPD), yet it remains underutilized, particularly among patients living in peripheral areas due to limited access, travel distance, and logistical barriers. Tele-pulmonary rehabilitation (TPR) has the potential to improve access to care, but its feasibility and effectiveness as a group-based intervention have not been well established. The aim of this study is to evaluate whether a group-based TPR program can improve treatment initiation and adherence compared to usual care, defined as referral to standard PR, among COPD patients living in peripheral areas. In addition, the study will assess the effect of the intervention on COPD exacerbations, symptom burden, quality of life, and patient satisfaction. This is a prospective randomized controlled trial that will enroll patients with COPD who are eligible for PR according to the Israeli health basket criteria and have not participated in PR in the past year. Participants will be randomly assigned to one of two groups: (1) referral to standard PR (control group), or (2) participation in a 12-week, twice-weekly, group-based TPR program delivered remotely via a dedicated application and video sessions (intervention group).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
24mo left

Started Jul 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Jul 2026Aug 2028

First Submitted

Initial submission to the registry

June 18, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 24, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

June 24, 2026

Status Verified

June 1, 2026

Enrollment Period

2 years

First QC Date

June 18, 2026

Last Update Submit

June 18, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Adherence to pulmonary rehabilitation Between the Study Groups

    Adherence will be defined as initiation of pulmonary rehabilitation in 3 months from study inclusion and completion of at least 50% (12 sessions) of the program (regular/remote based on allocation) within 6 months from inclusion.

    Assessed by a clinical research coordinator from enrollment to 6 months following study initiation.

Secondary Outcomes (18)

  • Safety of Tele-pulmonary Rehabilitation / Traditional Pulmonary Rehabilitation

    Assessed from enrollment to 6 months following study initiation.

  • Tele-pulmonary Rehabilitation / Traditional Pulmonary Rehabilitation Initiation Rate

    Assessed by a clinical research coordinator from enrollment to 6 months following study initiation.

  • Respiratory Symptoms Burden Assessed by CAT

    Assessed by a physician at baseline, and subsequent by the clinical research coordinator via phone call after 6 months following study initiation.

  • Number of Moderate and Severe COPD Exacerbations (6 months)

    Assessed by a physician at baseline, and subsequent by the clinical research coordinator via phone call after 6 months following study initiation.

  • Health-related Quality of Life Assessed by SGRQ (6 months)

    Assessed by a physician at baseline, and subsequent by the clinical research coordinator via phone call after 6 months following study initiation.

  • +13 more secondary outcomes

Study Arms (2)

Tele-Rehabilitation

EXPERIMENTAL

Participants will undergo a 12 weeks tele-rehabilitation program using a dedicated application. The intervention consists of 24 online sessions (twice weekly) led by a senior respiratory physiotherapist in groups of up to 4-6 participants.

Other: Tele-Rehabilitation

Control

NO INTERVENTION

Participants in the control group will be sent back to their referring physicians with a recommendation to initiate pulmonary rehabilitation as soon as possible, signed by a pulmonologist. The treating physicians will also be notified.

Interventions

Participants will undergo a 12 weeks tele-rehabilitation program using a dedicated application. The intervention consists of 24 online sessions (twice weekly) led by a senior respiratory physiotherapist in groups of up to 6 participants. The sessions include: 1) Supervised Exercise: Aerobic and resistance training using household items, stretching, and breathing techniques. 2) Remote Monitoring: Vital signs (heart rate and oxygen saturation) monitored every 10-15 minutes via a study-provided pulse oximeter. 3) Comprehensive Education: Guidance on lifestyle, nutrition, and physical activity. 4) Digital Support: The app provides activity tracking, symptom logging, session reminders, and guided home exercises. At the end of each session, every participant receives a personalized exercise plan based on their performance and preferences, which is displayed in the app.

Also known as: Tele-Pulmonary Rehabilitation
Tele-Rehabilitation

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and females Patients with COPD based on accepted criteria who are eligible for reimbursement of pulmonary rehabilitation (PR) according to the Israeli "health basket" criteria including one of the following:
  • FEV1 below 50%
  • Severe exacerbation (hospitalization) in the previous year
  • Two moderate exacerbations in the previous year
  • Willingness to initiate a PR or TPR programs.
  • Living in geographic peripheral area.
  • Ability to perform the TPR program or traditional PR activities as assessed by a member of the study team prior to enrollment.
  • Agree to participate, with signed informed consent.
  • Age \> 18.

You may not qualify if:

  • Uncontrolled comorbidity (e.g uncontrolled congestive heart failure).
  • Inability to operate the mobile application.
  • Without a mobile device or computer.
  • An exacerbation in the 2-months prior to randomization.
  • Completed PR program in the last 12 months.
  • Pregnancy.
  • Patients with cognitive impairment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tel Aviv Sourasky Medical Center

Tel Aviv, 6423906, Israel

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Telerehabilitation

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesTelemedicineDelivery of Health CarePatient Care ManagementHealth Services Administration

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
All outcomes will be assessed at similar time frames for both the intervention and control groups and filled in an identical form. All phone calls to assess the study outcomes will be performed by research assistances blinded to group allocation. All forms from each phone call will be stored in a single sealed box without details on group allocation. The data extraction from the forms for the study database will be performed at the end of the study by research assistants who will be blinded to group allocation. Statistical analysis will also be done by masking group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2026

First Posted

June 24, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

August 1, 2028

Last Updated

June 24, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations